Hostname: page-component-74656f9884-8rzl6 Total loading time: 0 Render date: 2026-11-06T01:43:22.211Z Has data issue: false hasContentIssue false

Theory of mind in the early course of schizophrenia: stability, symptom and neurocognitive correlates, and relationship with functioning

Published online by Cambridge University Press:  03 February 2015

J. Ventura*
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
A. Ered
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
D. Gretchen-Doorly
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
K. L. Subotnik
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
W. P. Horan
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA
G. S. Hellemann
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
K. H. Nuechterlein
Affiliation:
UCLA Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA UCLA Department of Psychology, Los Angeles, CA, USA
*
* Address for correspondence: J. Ventura, Ph.D., UCLA Department of Psychiatry, 300 Medical Plaza, Room 2243, Los Angeles, CA 90095-6968, USA. (Email: jventura@ucla.edu)
Rights & Permissions [Opens in a new window]

Abstract

Background

Numerous studies have reported links between theory of mind (ToM) deficits, neurocognition and negative symptoms with functional outcome in chronic schizophrenia patients. Although the ToM deficit has been observed in first-episode patients, fewer studies have addressed ToM as a possible trait marker, neurocognitive and symptom correlations longitudinally, and associations with later functioning.

Method

Recent-onset schizophrenia patients (n = 77) were assessed at baseline after reaching medication stabilization, and again at 6 months (n = 48). Healthy controls (n = 21) were screened, and demographically comparable with the patients. ToM was assessed with a Social Animations Task (SAT), in which the participants’ descriptions of scenes depicting abstract visual stimuli ‘interacting’ in three conditions (ToM, goal directed and random) were rated for degree of intentionality attributed to the figures and for appropriateness. Neurocognition, symptoms and role functioning were also assessed.

Results

On the SAT, patients had lower scores than controls for both intentionality (p < 0.01) and appropriateness (p < 0.01) during the ToM condition, at baseline and 6 months. The ToM deficit was stable and present even in remitted patients. Analyses at baseline and 6 months indicated that for patients, ToM intentionality and appropriateness were significantly correlated with neurocognition, negative symptoms and role functioning. The relationship between ToM and role functioning was mediated by negative symptoms.

Conclusions

The ToM deficit was found in recent-onset schizophrenia patients and appears to be moderately trait-like. ToM is also moderately correlated with neurocognition, negative and positive symptoms, and role functioning. ToM appears to influence negative symptoms which in turn makes an impact on role functioning.

Information

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2015 
Figure 0

Table 1. Sample differences at study entry for recent-onset schizophrenia patients (n = 77) and healthy controls (n = 21)

Figure 1

Fig. 1. (a) Model 1. Examination of theory of mind intentionality or appropriateness as a potential mediator of the relationship between neurocognition and role functioning using the Sobel test. (b) Model 2. Examination of negative symptoms as a potential mediator of the relationship between theory of mind intentionality or appropriateness and role functioning using the Sobel test. * p <  0.05.

Figure 2

Table 2. Cross-sectional group differences between patients at baseline (n = 77) and 6 months (n = 48) compared with controls at baseline only (n = 21) in SAT responses

Figure 3

Table 3. Cross-sectional correlations between neurocognition, theory of mind, negative symptoms, positive symptoms, and functioning in first-episode patients at baseline (n = 77) and 6-month follow-up (n = 48)

Figure 4

Table 4. Tests of mediation using the Sobel test (standardized values)